openPR Logo
Press release

Scienlodic Launches a Giveaway Campaign for Red Light Therapy Belt T100

07-27-2023 11:18 AM CET | Health & Medicine

Press release from: Scienlodic LLC

Scienlodic LLC

Scienlodic LLC

New York, July 26, 2023: Scienlodic, a leading brand of red light therapy devices, is excited to announce a giveaway campaign for its all-new red light therapy belt, T100. The campaign will run from July 26 to July 30, 2023, and will select 3 lucky winners to try out the T100 for free.

The T100 belt is a revolutionary product that combines red light therapy with 10 Hz and 40 Hz pulses to provide inside-out recovery for various health and wellness issues.

In a word, whether it's aching joints, sore muscles, or any inflammation that plagues your body, the Scienlodic T100 red light therapy wrap unleashes its powerful light to provide a wave of comfort like never before.

To access the giveaway campaign, participants need to follow these simple steps:
1. Like the giveaway post on Scienlodic's Instagram page [@scienlodic]
2. Follow Scienlodic on Instagram
3. Tag two friends in the comments section of the post and they will also have a chance to win
4. Repost the giveaway post to their Instagram story for an extra entry

The giveaway campaign is open to anyone who is 18 years of age or older and lives in the U.S., Canada, or the U.K. The winners will be randomly chosen and announced on July 31, 2023, on Scienlodic's Instagram page and contacted via direct message. The winners will receive A FREE T100 belt.

"We are thrilled to launch this giveaway campaign and share our innovative red light therapy belt T100 with our loyal customers and followers," said Alex Chen, the CEO of Scienlodic. "We believe that the T100 is advanced in the red light therapy industry, and we can't wait to hear the feedback from the winners."

For more information about Scienlodic and its products, please visit their website [www.scienlodic.com] or follow them on Instagram [@scienlodic].

Media Contact:
Klaus
Marketing Manager from Scienlodic, official@scienlodic.com

Raleigh NC 27614

About Scienlodic
Scienlodic is an emerging brand in the field of red light therapy, a natural and non-invasive treatment that uses light to stimulate healing and wellness. Founded in 2018 by Alex Chen, Scienlodic provides FDA-cleared devices that are portable and easy to use at home or on the go. Scienlodic's mission is to make red light therapy accessible for everyone. The products include red light therapy caps, belts, wrist pads, panels, and other light therapy devices that can help with various conditions, such as hair loss, pain relief, and weight control. For more information, visit www.scienlodic.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Scienlodic Launches a Giveaway Campaign for Red Light Therapy Belt T100 here

News-ID: 3147510 • Views:

More Releases for T100

Actinic Keratosis Market to Experience Notable Growth in Forecast Span by 2034, …
The Actinic Keratosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Actinic Keratosis pipeline products will significantly revolutionize the Actinic Keratosis market dynamics. DelveInsight's "Actinic Keratosis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Actinic Keratosis, historical and forecasted epidemiology as well as the Actinic Keratosis market trends in the United
Actinic Keratosis Pipeline: 10+ Key Players Driving Innovation in Non-Invasive D …
The actinic keratosis (AK) treatment landscape is expanding rapidly, driven by key players such as Biofrontera, Almirall, and Leo Pharma. The current pipeline includes next-generation topical therapies, field-directed treatments, and photodynamic innovations designed to enhance efficacy and patient compliance. With an emphasis on early intervention and non-invasive strategies, these developments aim to reduce progression to squamous cell carcinoma while offering more convenient and tolerable options for patients with multiple lesions. DelveInsight's
Actinic Keratosis Market Expected to Experience Major Growth by 2034, According …
The Actinic Keratosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Actinic Keratosis pipeline products will significantly revolutionize the Actinic Keratosis market dynamics. DelveInsight's "Actinic Keratosis Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Actinic Keratosis, historical and forecasted epidemiology as well as the Actinic Keratosis market trends in the United
Actinic Keratosis Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Actinic Keratosis pipeline constitutes 10+ key companies continuously working towards developing 10+ Actinic Keratosis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. "Actinic Keratosis Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Actinic Keratosis Market. The Actinic
Actinic Keratosis Market Growth to Accelerate in Forecast Period (2023-2032), De …
The Key Actinic Keratosis Companies in the market include - Bausch Health Companies, Sandoz Pharmaceuticals, Athenex/ Almirall, Vidac Pharma, G&E Herbal Biotechnology, Vidac Pharma, DFB Soria, LLC, Coegin Pharma AB, and others. The Actinic Keratosis market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Actinic Keratosis pipeline products will significantly revolutionize the Actinic Keratosis market dynamics. DelveInsight's "Actinic Keratosis Market
Silvercnc Introduces 5 Axis Rotary Table Upgrade
Silvercnc is proud to announce an upgrade available for their machining customers with the introduction of the 5 Axis Rotary Table. This new rotary table can provide increased accuracy and precision in machining operations on parts such as complex contours and components with complex geometries. This product allows for a five-sided finish that would otherwise be difficult or impossible to achieve with standard equipment. The 5 Axis Rotary Table enables